HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lee S Schwartzberg Selected Research

OF 4647

11/2020Actionable co-alterations in breast tumors with pathogenic mutations in the homologous recombination DNA damage repair pathway.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Lee S Schwartzberg Research Topics

Disease

45Breast Neoplasms (Breast Cancer)
01/2021 - 02/2005
40Neoplasms (Cancer)
01/2021 - 01/2004
21Vomiting
01/2019 - 02/2007
21Nausea
01/2019 - 02/2007
11Neutropenia
01/2020 - 07/2005
8Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2019 - 06/2009
8Colorectal Neoplasms (Colorectal Cancer)
08/2017 - 09/2007
7Febrile Neutropenia
10/2018 - 02/2005
5Triple Negative Breast Neoplasms
10/2021 - 01/2018
5Neoplasm Metastasis (Metastasis)
01/2021 - 01/2013
5Disease Progression
01/2020 - 11/2009
4Diarrhea
12/2017 - 11/2009
4Fatigue
01/2016 - 11/2009
3Hypersensitivity (Allergy)
06/2018 - 06/2007
3Exanthema (Rash)
05/2015 - 01/2010
3Non-Hodgkin Lymphoma (Lymphosarcoma)
07/2014 - 09/2008
3Anemia
05/2006 - 01/2004
2Brain Neoplasms (Brain Tumor)
09/2017 - 01/2017
2Pancreatic Neoplasms (Pancreatic Cancer)
01/2017 - 01/2013
2Constipation
09/2015 - 09/2015
2Headache (Headaches)
09/2015 - 09/2015
2Melanoma (Melanoma, Malignant)
06/2015 - 06/2007
2Carcinoma (Carcinomatosis)
02/2013 - 08/2002
1Bone Diseases (Bone Disease)
01/2021

Drug/Important Bio-Agent (IBA)

13Hormones (Hormone)IBA
01/2021 - 01/2010
9Capecitabine (Xeloda)FDA Link
12/2017 - 08/2009
8Docetaxel (Taxotere)FDA Link
01/2020 - 02/2005
8Bevacizumab (Avastin)FDA Link
08/2017 - 09/2007
7AnthracyclinesIBA
12/2018 - 09/2015
6pegfilgrastim (Neulasta)FDA Link
01/2020 - 02/2005
6Estrogen ReceptorsIBA
01/2020 - 01/2017
6Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2020 - 09/2015
6taxaneIBA
12/2017 - 08/2009
6Paclitaxel (Taxol)FDA LinkGeneric
09/2017 - 08/2009
6Panitumumab (Vectibix)FDA Link
08/2017 - 01/2011
5human ERBB2 proteinIBA
01/2019 - 05/2013
5Trastuzumab (Herceptin)FDA Link
01/2019 - 06/2014
5Pharmaceutical PreparationsIBA
12/2018 - 10/2013
5GemcitabineFDA Link
09/2017 - 01/2011
4Progesterone Receptors (Progesterone Receptor)IBA
01/2021 - 01/2017
4Biomarkers (Surrogate Marker)IBA
01/2020 - 03/2015
4Granulocyte Colony-Stimulating Factor (G-CSF)IBA
01/2020 - 07/2014
4Fulvestrant (Faslodex)FDA Link
01/2020 - 02/2014
4AntiemeticsIBA
01/2019 - 07/2007
4Palonosetron (Aloxi)FDA Link
01/2019 - 07/2012
4Neurokinin-1 Receptor AntagonistsIBA
12/2018 - 11/2011
4Dexamethasone (Maxidex)FDA LinkGeneric
12/2018 - 09/2015
4rolapitantIBA
01/2018 - 09/2015
4Erlotinib Hydrochloride (CP 358,774)FDA Link
07/2017 - 11/2009
4Carboplatin (JM8)FDA LinkGeneric
07/2017 - 06/2009
4Cetuximab (Erbitux)FDA Link
06/2016 - 01/2009
3Epidermal Growth Factor (EGF)IBA
01/2021 - 01/2020
3eflapegrastimIBA
01/2020 - 01/2018
3Androgen Receptors (Androgen Receptor)IBA
11/2019 - 01/2017
3Biosimilar PharmaceuticalsIBA
01/2019 - 01/2018
3Colony-Stimulating Factors (Colony Stimulating Factor)IBA
10/2018 - 10/2013
3Filgrastim (Neupogen)FDA Link
10/2018 - 10/2013
3Sorafenib (BAY 43-9006)FDA Link
12/2017 - 05/2013
3etirinotecan pegolIBA
09/2017 - 11/2015
35-HT3 Serotonin Receptors (5 HT3 Receptor)IBA
09/2015 - 07/2012
3Cisplatin (Platino)FDA LinkGeneric
09/2015 - 01/2011
3ErbB Receptors (EGF Receptor)IBA
05/2015 - 01/2010
3Leucovorin (Folinic Acid)FDA Link
07/2014 - 08/2002
3Fluorouracil (Carac)FDA LinkGeneric
07/2014 - 08/2002
3Rituximab (Mabthera)FDA Link
06/2011 - 09/2008
2Immune Checkpoint InhibitorsIBA
04/2020 - 08/2016
2LigandsIBA
11/2019 - 01/2018
2fosaprepitantFDA Link
06/2018 - 01/2018
2Polysorbates (PSML)FDA Link
06/2018 - 01/2018
2enzalutamideIBA
01/2018 - 08/2017
2Serotonin (5 Hydroxytryptamine)IBA
01/2018 - 09/2015
2Aromatase InhibitorsIBA
01/2018 - 04/2009
2Estrogens (Estrogen)FDA Link
12/2017 - 08/2017
2Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
12/2017 - 10/2013
2eribulinFDA Link
09/2017 - 01/2016
2PlatinumIBA
08/2017 - 02/2013
2Granisetron (Kytril)FDA LinkGeneric
08/2016 - 06/2016
2Antineoplastic Agents (Antineoplastics)IBA
01/2016 - 09/2015
2AlbuminsIBA
01/2016 - 02/2013
2VaccinesIBA
06/2015 - 06/2007
2Lapatinib (GW572016)FDA Link
05/2015 - 01/2010
2Taxoids (Taxanes)IBA
05/2015 - 08/2009
2motesanib diphosphateIBA
05/2015 - 01/2011
2Oxaliplatin (Eloxatin)FDA LinkGeneric
07/2014 - 09/2007
2Pemetrexed (MTA)FDA Link
11/2013 - 10/2013
2Albumin-Bound PaclitaxelFDA Link
02/2013 - 04/2012
2Hemoglobins (Hemoglobin)IBA
05/2006 - 07/2005
1Poly Adenosine Diphosphate RiboseIBA
01/2021
1olaparibIBA
01/2021
1Poly(ADP-ribose) Polymerase InhibitorsIBA
11/2020
1OF 4647IBA
11/2020

Therapy/Procedure

45Drug Therapy (Chemotherapy)
01/2021 - 01/2004
29Therapeutics
10/2021 - 08/2002
6Radiotherapy
01/2017 - 06/2009
4Immunotherapy
11/2020 - 06/2007
4Drug Tapering
07/2014 - 11/2009
3Neoadjuvant Therapy
10/2021 - 01/2021
3Biological Therapy
03/2016 - 04/2014
2Aftercare (After-Treatment)
09/2015 - 01/2013
2Treatment Delay
10/2013 - 11/2009